array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(145) "Bio-Rad launches first Ultrasensitive Multiplexed Digital PCR Assay for breast cancer mutation detection in clinical research | Cambridge Network"
["snippet_en"]=>
string(204) "Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600TM Droplet DigitalTM PCR System"
["url"]=>
string(130) "https://www.cambridgenetwork.co.uk/news/bio-rad-launches-first-ultrasensitive-multiplexed-digital-pcr-assay-breast-cancer-mutation"
["image_url"]=>
NULL
["source"]=>
string(22) "cambridgenetwork.co.uk"
["publication_date"]=>
string(10) "2024-04-03"
["categories"]=>
array(4) {
[0]=>
string(10) "New Market"
[1]=>
string(5) "R & D"
[2]=>
string(5) "Legal"
[3]=>
string(14) "Product Launch"
}
}
[1]=>
array(7) {
["title_en"]=>
string(37) "Bio-Rad launches validated antibodies"
["snippet_en"]=>
string(110) "Antibodies validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits to enable immunostaining"
["url"]=>
string(127) "https://www.selectscience.net/product-news/bio-rad-launches-validated-antibodies-for-rare-cell-and-ctc-enumeration/?artID=60938"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6139cb93-a8d5-4266-a000-a6ba2e8d5e58"
["source"]=>
string(17) "selectscience.net"
["publication_date"]=>
string(10) "2024-03-26"
["categories"]=>
array(1) {
[0]=>
string(14) "Product Launch"
}
}
[2]=>
array(7) {
["title_en"]=>
string(91) "Bio-Rad Launches Validated Antibodies for Rare Cell and Circulating Tumour Cell Enumeration"
["snippet_en"]=>
string(200) "Bio-Rad Laboratories have announced the launch of validated antibodies for rare cell and circulating tumour cell enumeration validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits."
["url"]=>
string(175) "https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/new-drug-development-approvals-regulatory-news/bio-rad-launches-validated-antibodies-for-rare-cell-and-circ/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9d51bbf8-63d3-4d36-8706-79227e2cae25"
["source"]=>
string(32) "pharmaceuticalmanufacturer.media"
["publication_date"]=>
string(10) "2024-03-26"
["categories"]=>
array(1) {
[0]=>
string(14) "Product Launch"
}
}
[3]=>
array(7) {
["title_en"]=>
string(157) "Bio-Rad launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for cell and gene therapy production | Cambridge Network"
["snippet_en"]=>
string(136) "Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet DigitalTM PCR During Cell and Gene Therapy Production"
["url"]=>
string(131) "https://www.cambridgenetwork.co.uk/news/bio-rad-launches-vericheck-ddpcr-replication-competent-lentivirus-and-replication-competent"
["image_url"]=>
NULL
["source"]=>
string(22) "cambridgenetwork.co.uk"
["publication_date"]=>
string(10) "2024-02-28"
["categories"]=>
array(2) {
[0]=>
string(17) "Production Issues"
[1]=>
string(14) "Product Launch"
}
}
[4]=>
array(7) {
["title_en"]=>
string(137) "Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production"
["snippet_en"]=>
string(136) "Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet DigitalTM PCR During Cell and Gene Therapy Production"
["url"]=>
string(173) "https://www.the-scientist.com/bio-rad-launches-vericheck-ddpcr-replication-competent-lentivirus-and-replication-competent-aav-kits-for-cell-and-gene-therapy-production-71682"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/34837ded-780c-4628-bfc1-5e5856f69463"
["source"]=>
string(17) "the-scientist.com"
["publication_date"]=>
string(10) "2024-02-27"
["categories"]=>
array(2) {
[0]=>
string(17) "Production Issues"
[1]=>
string(14) "Product Launch"
}
}
[5]=>
array(7) {
["title_en"]=>
string(73) "Bio-Rad launches third in series of educational quality control workbooks"
["snippet_en"]=>
string(79) "Cost of Quality takes center stage in latest installment of educational series."
["url"]=>
string(128) "https://www.mlo-online.com/management/article/53096252/bio-rad-launches-third-in-series-of-educational-quality-control-workbooks"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/17475f36-13eb-443b-89ae-4a573ca3e932"
["source"]=>
string(14) "mlo-online.com"
["publication_date"]=>
string(10) "2024-02-12"
["categories"]=>
array(3) {
[0]=>
string(10) "New Market"
[1]=>
string(14) "Product Launch"
[2]=>
string(37) "Product Design & Lifecycle Management"
}
}
[6]=>
array(7) {
["title_en"]=>
string(70) "Bio-Rad Launches NGC Fraction Collector for NGC Chromatography Systems"
["snippet_en"]=>
string(70) "Bio-Rad Launches NGC Fraction Collector for NGC Chromatography Systems"
["url"]=>
string(120) "https://www.bioprocessintl.com/bioprocess-insider/bio-rad-launches-ngc-fraction-collector-for-ngc-chromatography-systems"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1dbc9217-13c2-403b-a07a-1a4ff11cf96b"
["source"]=>
string(18) "bioprocessintl.com"
["publication_date"]=>
string(10) "2024-02-07"
["categories"]=>
array(1) {
[0]=>
string(14) "Product Launch"
}
}
[7]=>
array(7) {
["title_en"]=>
string(66) "Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers"
["snippet_en"]=>
string(140) "The PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers are the latest additions to the Bio-Rad portfolio of conventional PCR thermal cyclers."
["url"]=>
string(118) "https://www.the-scientist.com/the-marketplace/bio-rad-launches-ptc-tempo-48-48-and-ptc-tempo-384-thermal-cyclers-71399"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/eb1f4136-156a-4dfe-9784-814be90ede0f"
["source"]=>
string(17) "the-scientist.com"
["publication_date"]=>
string(10) "2023-09-28"
["categories"]=>
array(1) {
[0]=>
string(14) "Product Launch"
}
}
[8]=>
array(7) {
["title_en"]=>
string(81) "Bio-Rad Launches First StarBrightTM Red Dye and Extends Range of Antibody Markers"
["snippet_en"]=>
string(206) "Bio-Rad Laboratories announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range. With 29 additional targets the range also includes dog, cow, and pig targets."
["url"]=>
string(143) "https://www.technologynetworks.com/analysis/product-news/bio-rad-launches-first-starbright-red-dye-and-extends-range-of-antibody-markers-378449"
["image_url"]=>
NULL
["source"]=>
string(22) "technologynetworks.com"
["publication_date"]=>
string(10) "2023-09-05"
["categories"]=>
array(2) {
[0]=>
string(14) "Product Launch"
[1]=>
string(18) "Expansion & Growth"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600TM Droplet DigitalTM PCR System
Bio-Rad Laboratories have announced the launch of validated antibodies for rare cell and circulating tumour cell enumeration validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits.
Bio-Rad Laboratories announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range. With 29 additional targets the range also includes dog, cow, and pig targets.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
